Article
IL6R inhibits viability and apoptosis of pancreatic beta-cells in type 2 diabetes mellitus…
Diabetes, Metabolic Syndrome and Obesity · 2019 · Wu X, Yu T, Ji N, Huang Y, Gao L, Shi W, Yan Y, Li H, Ma L, Wu K, Wu Z
Key facts
| Title | IL6R inhibits viability and apoptosis of pancreatic beta-cells in type 2 diabetes mellitus via regulation by miR-22 of the JAK/STAT signaling pathway |
|---|---|
| First author | Wu X, Yu T, Ji N, Huang Y, Gao L, Shi W, Yan Y, Li H, Ma L, Wu K, Wu Z |
| Journal | Diabetes, Metabolic Syndrome and Obesity |
| Published | Aug 29, 2019 |
| DOI | 10.2147/DMSO.S211700 |
| Devices mentioned | 211700, K800552, K801561, K853723, K860811, K862004, K874160, K874609, K912581, K915561, K915840, K920529 and 14 more |
| Product codes mentioned | EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, JLX, KKX, KQP and 1 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1